These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36145313)

  • 1. Hybrid Molecules as Potential Drugs for the Treatment of HIV: Design and Applications.
    Liman W; Ait Lahcen N; Oubahmane M; Hdoufane I; Cherqaoui D; Daoud R; El Allali A
    Pharmaceuticals (Basel); 2022 Aug; 15(9):. PubMed ID: 36145313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Computer-aided Antiviral Drug Design Targeting HIV-1 Integrase and Reverse Transcriptase Associated Ribonuclease H.
    Yang F; Yang J; Zhang Z; Tu G; Yao X; Xue W; Zhu F
    Curr Med Chem; 2022; 29(10):1664-1676. PubMed ID: 34238145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of HIV-1 reverse transcriptase and integrase dual inhibitors: Recent advances and developments.
    Gill MSA; Hassan SS; Ahemad N
    Eur J Med Chem; 2019 Oct; 179():423-448. PubMed ID: 31265935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting into the Substrate Dominance: Pharmacophore and Structure-Based Approaches toward Inhibiting Human Immunodeficiency Virus Reverse Transcriptase-Associated Ribonuclease H.
    Wang L; Sarafianos SG; Wang Z
    Acc Chem Res; 2020 Jan; 53(1):218-230. PubMed ID: 31880912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel method for simultaneous quantification of phenotypic resistance to maturation, protease, reverse transcriptase, and integrase HIV inhibitors based on 3'Gag(p2/p7/p1/p6)/PR/RT/INT-recombinant viruses: a useful tool in the multitarget era of antiretroviral therapy.
    Weber J; Vazquez AC; Winner D; Rose JD; Wylie D; Rhea AM; Henry K; Pappas J; Wright A; Mohamed N; Gibson R; Rodriguez B; Soriano V; King K; Arts EJ; Olivo PD; Quiñones-Mateu ME
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3729-42. PubMed ID: 21628544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Potential of Indole Derivatives as Anti-HIV Agents: A Mini-review.
    Chen Q; Wu C; Zhu J; Li E; Xu Z
    Curr Top Med Chem; 2022; 22(12):993-1008. PubMed ID: 34636313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragment Based Strategies for Discovery of Novel HIV-1 Reverse Transcriptase and Integrase Inhibitors.
    Latham CF; La J; Tinetti RN; Chalmers DK; Tachedjian G
    Curr Top Med Chem; 2016; 16(10):1135-53. PubMed ID: 26324045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of quinoxaline compounds as anti-HIV agents targeting reverse transcriptase enzyme.
    Fabian L; Taverna Porro M; Gómez N; Salvatori M; Turk G; Estrin D; Moglioni A
    Eur J Med Chem; 2020 Feb; 188():111987. PubMed ID: 31893549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitors.
    Santos LH; Ferreira RS; Caffarena ER
    Mem Inst Oswaldo Cruz; 2015 Nov; 110(7):847-64. PubMed ID: 26560977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of human immunodeficiency virus as a target for antiretroviral therapy.
    Semenova EA; Johnson AA; Marchand C; Pommier Y
    Curr Opin HIV AIDS; 2006 Sep; 1(5):380-7. PubMed ID: 19372837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Reverse Transcriptase/Integrase Dual Inhibitors: A Review of Recent Advances and Structure-activity Relationship Studies.
    Mahboubi-Rabbani M; Abbasi M; Hajimahdi Z; Zarghi A
    Iran J Pharm Res; 2021; 20(2):333-369. PubMed ID: 34567166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Combined Approach of Pharmacophore Modeling, QSAR Study, Molecular Docking and In silico ADME/Tox Prediction of 4-Arylthio & 4-Aryloxy-3- Iodopyridine-2(1H)-one Analogs to Identify Potential Reverse Transcriptase Inhibitor: Anti-HIV Agents.
    Panigrahi D; Mishra A; Sahu SK; Azam MA; Vyshaag CM
    Med Chem; 2022; 18(1):51-87. PubMed ID: 33319692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV.
    Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
    J Biomol Struct Dyn; 2019 Jan; 37(1):131-146. PubMed ID: 29268664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches.
    Tarrago-Litvak L; Andreola ML; Fournier M; Nevinsky GA; Parissi V; de Soultrait VR; Litvak S
    Curr Pharm Des; 2002; 8(8):595-614. PubMed ID: 11945161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered viral fitness and drug susceptibility in HIV-1 carrying mutations that confer resistance to nonnucleoside reverse transcriptase and integrase strand transfer inhibitors.
    Hu Z; Kuritzkes DR
    J Virol; 2014 Aug; 88(16):9268-76. PubMed ID: 24899199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of metronidazole derivatives and flavonoids as potential non-nucleoside reverse transcriptase inhibitors using combined ligand- and structure-based approaches.
    Cutinho PF; Roy J; Anand A; Cheluvaraj R; Murahari M; Chimatapu HSV
    J Biomol Struct Dyn; 2020 Apr; 38(6):1626-1648. PubMed ID: 31046644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Binding Mode and Prospective Structural Features of Novel Nef Protein Inhibitors as Potential Anti-HIV Drugs.
    Moonsamy S; Bhakat S; Ramesh M; Soliman ME
    Cell Biochem Biophys; 2017 Mar; 75(1):49-64. PubMed ID: 27981421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research progress of dual inhibitors targeting HIV-1 reverse transcriptase and integrase].
    Liu H; Zhan P; Liu XY
    Yao Xue Xue Bao; 2013 Apr; 48(4):466-76. PubMed ID: 23833931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in silico pharmacological approach toward the discovery of potent inhibitors to combat drug resistance HIV-1 protease variants.
    Nayak C; Chandra I; Singh SK
    J Cell Biochem; 2019 Jun; 120(6):9063-9081. PubMed ID: 30506751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.